January 1, 2017
In this video, Dr. Hwang talks about changes to the protocols for examining specimens from patients with lung cancer
Watch as Dr. David Hwang talks about protocol changes when examining specimens from patients with lung cancer. He also talks about changes made to the TMN classification, eighth edition and potential impacts on pathologic staging of lung cancers.
Watch the video for the CAP education session about lung cancer
About the presenter, Dr. David Hwang
David Hwang, MD, FRCPC, is a Pathologist at University Health Network (UHN) and an Associate Professor in the Department of Laboratory Medicine & Pathobiology at the University of Toronto, Ontario, Canada. He completed his MD and PhD degrees at the University of Toronto, followed by residency training in Anatomical Pathology.
About the CAP education sessions
The Partnership, the Canadian Association of Pathologists (CAP-ACP), and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.